Skip To Main Content

News & Studies Articles

Sort by

Filtera

Återställ
  • News & Studies Articles
FLUNITY-HD Study Demonstrated the<br>Superior Protection Beyond Flu of High-Dose Flu Vaccine vs Standard-Dose Flu Vaccine<sup>*</sup>

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

EVEREST study highlights

EVEREST study: First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

Understanding Disease Modification in Atopic Dermatitis

Understanding Disease Modification in Atopic Dermatitis

EFLUELDA - Seasonal high dose flu vaccine

EFLUELDA - Seasonal high dose flu vaccine

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3

Understanding Autoimmune T1D & The Value of Early Detection

Understanding Autoimmune T1D & The Value of Early Detection

Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.1-2 The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.4-8

IL-4 and IL-13: the key and central drivers of type 2 inflammation<sup>1-2,6-7</sup>

IL-4 and IL-13: the key and central drivers of type 2 inflammation

When a Child Gets Autoimmune Type 1 Diabetes

When a Child Gets Autoimmune Type 1 Diabetes

Parent's experiences of stage 3 diagnosis of T1D.

Sleep and QOL: the full impact on patients coping with the burden of AD

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Real-life stories from people living with autoimmune T1D

Real-life stories from people living with autoimmune T1D

The progression of autoimmune type 1 diabetes (T1D) is gradual, often detectable months or even years before symptoms arise.1–3 Through proactive screening, we can identify the condition well in advance.3 Meet our ambassadors living with autoimmune T1D and discover the risk factors to look out for when considering who to screen.

Does your patient have an existing autoimmune condition? Check for autoimmune type 1 diabetes!

Does your patient have an existing autoimmune condition? Check for autoimmune type 1 diabetes!

Individuals living with other associated autoimmune diseases like celiac disease or autoimmune thyroid disease, are at an increased risk of developing autoimmune type 1 diabetes (T1D) and should be appropriately screened.1-6

Early detection of autoimmune type 1 diabetes could reduce the risk of diabetic ketoacidosis

Early detection of autoimmune type 1 diabetes could reduce the risk of diabetic ketoacidosis

Delay in screening for autoimmune type 1 diabetes (T1D) can increase the risk of diabetic ketoacidosis (DKA) at diagnosis—a critical complication that is potentially life-threatening and may result in long-term poor glycemic control and neurological complications.1,2 By identifying autoimmune T1D early, you can significantly lower the risk of DKA at diagnosis.3,4